Baltimore, MD, United States of America

Beth L Laube


Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 692(Granted Patents)


Company Filing History:


Years Active: 1988-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Insulin Delivery: The Contributions of Beth L. Laube

Introduction

Beth L. Laube is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of pharmaceutical delivery systems. With a total of 4 patents to her name, she has focused her research on improving methods for administering insulin, particularly through inhalation techniques. Her work has the potential to revolutionize how patients manage their diabetes.

Latest Patents

One of Laube's latest patents is a method of administering insulin that involves delivering a protein, specifically insulin, to the lungs. This innovative method produces an aerosolized mist of small particles in a medicament delivery chamber. The design ensures that the distance from the chamber to the patient's mouth slows the speed of aerosol particles entering the mouth, while the flow rate through the chamber is regulated to less than about 30 liters per minute. This approach has been shown to achieve a medication penetration into the lungs of approximately 90%.

Another notable patent is her medication delivery system, which is an improved, compact apparatus for inhaling pharmaceutical aerosols. This device enhances aerosol deposition to the bronchiolus while minimizing deposition in the oropharynx. The volumetric flow rate is controlled using orifices at the far end of the rigid holding chamber. Additionally, the apparatus is designed for ease of use, allowing patients to inhale medication at the correct point in their respiratory cycle. When not in use, the device can be folded to reduce its size, making it more convenient for patients.

Career Highlights

Beth L. Laube is affiliated with The Johns Hopkins University, where she continues to advance her research in pharmaceutical delivery systems. Her innovative work has garnered attention in the medical community, particularly for its implications in diabetes management.

Collaborations

Laube has collaborated with notable colleagues, including Bart J. Zoltan and George K. Adams, III, contributing to the development of her patented technologies.

Conclusion

Beth L. Laube's contributions to insulin delivery systems exemplify the impact of innovative thinking in healthcare. Her patents not only enhance the efficacy of medication delivery but also improve the quality of life for patients managing diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…